BioMarin Pharmaceutical (BMRN) News Today $59.93 +0.52 (+0.88%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMRN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Sherbrooke Park Advisers LLC Buys Shares of 5,510 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Sherbrooke Park Advisers LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 5,510 shares of the biotechnology company's stock, valued at approximaMay 21 at 5:42 AM | marketbeat.comGotham Asset Management LLC Lowers Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Gotham Asset Management LLC lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 49.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,734 shares of the biotechnology company's stock after selliMay 21 at 4:12 AM | marketbeat.com12,496 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Siemens Fonds Invest GmbHSiemens Fonds Invest GmbH bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 12,496 shares of the biotechnology company's stock, valued at approximately $821,000. Several other iMay 20 at 5:57 AM | marketbeat.com14,900 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 14,900 shares of the biotechnology company's stock, valued at approximately $979,000May 20 at 5:29 AM | marketbeat.comNuveen Asset Management LLC Has $66.19 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Nuveen Asset Management LLC lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 17.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,006,922 shares of the bioMay 20 at 4:55 AM | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by BrokeragesBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has earned an average rating of "Moderate Buy" from the twenty-three ratings firms that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and seventeen have given a buy rating toMay 20 at 2:18 AM | marketbeat.comBioMarin: Inozyme Acquisition Falls Short Of Offsetting Looming Revenue Risks (Downgrade)May 19 at 8:00 AM | seekingalpha.comStrategic Acquisition of INZY Boosts BioMarin’s Growth Potential and Pipeline ExpansionMay 19 at 7:24 AM | tipranks.comRaiffeisen Bank International AG Invests $1.03 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Raiffeisen Bank International AG acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 15,658 shares of the biotechnology company's stock, valued at approximately $1,May 19 at 6:05 AM | marketbeat.comBioMarin Expands Rare Disease Portfolio with $270M Inozyme AcquisitionMay 18 at 10:31 AM | insidermonkey.comBioMarin Expands Rare Disease Portfolio with $270M Inozyme AcquisitionMay 18 at 9:40 AM | msn.com60,741 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Point72 Europe London LLPPoint72 Europe London LLP purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 60,741 shares of the biotechnology company's stMay 17, 2025 | marketbeat.comEnsign Peak Advisors Inc Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Ensign Peak Advisors Inc cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 8.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 61,868 shares of the biotechnology company's stock after selling 5,995 shares duriMay 17, 2025 | marketbeat.comBioMarin Pharmaceutical Inc.: BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme PharmaMay 16, 2025 | finanznachrichten.deBioMarin to Acquire Inozyme Pharma for $270 MillionMay 16, 2025 | marketwatch.comBMRN Q1 Earnings Call: BioMarin Outperforms on Revenue and Expands Pipeline ProgressMay 16, 2025 | finance.yahoo.comBioMarin Pharmaceutical: Balancing Opportunities and Risks Amid Inozyme Acquisition and Market ChallengesMay 16, 2025 | tipranks.comBioMarin Pharmaceutical’s Strategic Growth and Market Potential: A Buy Rating by Yun ZhongMay 16, 2025 | tipranks.comInozyme Pharma Merges with BioMarin for $270 MillionMay 16, 2025 | tipranks.comBioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme PharmaMay 16, 2025 | prnewswire.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 11,840 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 78.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 26,840 shares of the biotechnology companMay 16, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Small-Cap Healthcare Stocks Hedge Funds Are BuyingMay 14, 2025 | msn.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Increased by Hudson Bay Capital Management LPHudson Bay Capital Management LP lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 460,000 shares of the biotechnology company's stock after puMay 13, 2025 | marketbeat.comFORA Capital LLC Lowers Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)FORA Capital LLC decreased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 87.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,225 shares of the biotechnology coMay 13, 2025 | marketbeat.comBioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology MeetingsMay 12, 2025 | prnewswire.comMercer Global Advisors Inc. ADV Has $1.19 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Mercer Global Advisors Inc. ADV grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 121.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,103 shares of the biotechnology company'May 12, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 19,548 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Schonfeld Strategic Advisors LLC reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 63.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,100 sharesMay 12, 2025 | marketbeat.comShareholders Will Be Pleased With The Quality of BioMarin Pharmaceutical's (NASDAQ:BMRN) EarningsMay 10, 2025 | uk.finance.yahoo.comClearline Capital LP Purchases 57,710 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Clearline Capital LP raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 18.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 377,482 shares of the biotechnology company's sMay 10, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 10, 2025 | finance.yahoo.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Position Lowered by Balyasny Asset Management L.P.Balyasny Asset Management L.P. trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 64.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 337,103 shares of the biotechnology company'sMay 10, 2025 | marketbeat.comAlgert Global LLC Makes New $2.77 Million Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Algert Global LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 42,095 shares of the biotechnology company's stock, valued at approximately $2,May 10, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 9, 2025 | insidermonkey.comBayesian Capital Management LP Sells 9,722 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Bayesian Capital Management LP lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 46.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,100 shares of the biotechnology company'sMay 8, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Stocks That Will Make You Rich In 3 YearsMay 7, 2025 | msn.comBioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $104.00 at The Goldman Sachs GroupThe Goldman Sachs Group cut their price objective on shares of BioMarin Pharmaceutical from $124.00 to $104.00 and set a "buy" rating for the company in a research report on Monday.May 7, 2025 | marketbeat.comCristin Hubbard Sells 273 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) StockMay 7, 2025 | insidertrades.comThe Manufacturers Life Insurance Company Has $10.14 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)The Manufacturers Life Insurance Company trimmed its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 3.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 154,296 shares of the biotechnology company's stoMay 7, 2025 | marketbeat.comBeacon Pointe Advisors LLC Sells 4,906 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Beacon Pointe Advisors LLC trimmed its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 46.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,764 shares of the biotechnology company's stock after selling 4,906May 7, 2025 | marketbeat.comAxa S.A. Has $37.57 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Axa S.A. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 571,538 shares of the biotechnology company's stock after purchasing an adMay 6, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Northern Trust CorpNorthern Trust Corp grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 16.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,725,039 shares of the biotechnology company'sMay 6, 2025 | marketbeat.comFY2025 EPS Estimates for BMRN Boosted by Cantor FitzgeraldBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2025 EPS estimates for BioMarin Pharmaceutical in a note issued to investors on Friday, May 2nd. Cantor Fitzgerald analyst O. Brayer now forecasts that the biotechnology company wilMay 6, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call TranscriptMay 3, 2025 | msn.comAQR Capital Management LLC Buys 685,099 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)AQR Capital Management LLC raised its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 114.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,283,599 sharesMay 3, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Dimensional Fund Advisors LPDimensional Fund Advisors LP lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,152,913 shares of the biotechnology company's stock after selling 186,8May 3, 2025 | marketbeat.com4BMRN : A Look Into Biomarin Pharmaceutical Inc's Price Over EarningsMay 2, 2025 | benzinga.comBioMarin Pharmaceutical (NASDAQ:BMRN) Beats Q1 Sales TargetsMay 2, 2025 | msn.comPrice T Rowe Associates Inc. MD Has $38.94 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Price T Rowe Associates Inc. MD reduced its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 10.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 592,393 shares of tMay 2, 2025 | marketbeat.comQ1 2025 BioMarin Pharmaceutical Inc Earnings Call TranscriptMay 2, 2025 | gurufocus.comBioMarin Pharmaceutical Inc. (BMRN) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.160.65▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼2111▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today INCY News Today EXEL News Today NBIX News Today EXAS News Today RGEN News Today HALO News Today MDGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMRN Stock Free BMRN Stock Alerts